# Rocket Pharmaceuticals
 (stock symbol: RCKT) Logo in transparent PNG format

## Rocket Pharmaceuticals
 Logo large

### Rocket Pharmaceuticals
 Logo large Download PNG (16.09 KB)

![Rocket Pharmaceuticals
 Logo large Download PNG (16.09 KB)](/img/orig/RCKT_BIG-f6836dac.png)

## Rocket Pharmaceuticals
 Logo icon format

### Rocket Pharmaceuticals
 Logo icon format Download PNG (17.01 KB)

![Rocket Pharmaceuticals
 Logo icon format Download PNG (17.01 KB)](/img/orig/RCKT-44e5e666.png)

## About Rocket Pharmaceuticals


Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones EnergÃ©ticas, Medioambientales y TecnolÃ³gicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.

1. Website domain: rocketpharma.com
2. Employees: 151
3. Marketcap: $1.42 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
